These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11113476)

  • 1. Recent advances in the protocols of transgenic mouse mutation assays.
    Nohmi T; Suzuki T; Masumura K
    Mutat Res; 2000 Nov; 455(1-2):191-215. PubMed ID: 11113476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections.
    Nohmi T; Katoh M; Suzuki H; Matsui M; Yamada M; Watanabe M; Suzuki M; Horiya N; Ueda O; Shibuya T; Ikeda H; Sofuni T
    Environ Mol Mutagen; 1996; 28(4):465-70. PubMed ID: 8991079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cII, gpt, and Spi⁻ gene mutation assays in transgenic mice and rats.
    Manjanatha MG; Cao X; Shelton SD; Mittelstaedt RA; Heflich RH
    Methods Mol Biol; 2013; 1044():97-119. PubMed ID: 23896873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of shuttle vectors for mutation analysis in transgenic mice and rats.
    Dycaico MJ; Provost GS; Kretz PL; Ransom SL; Moores JC; Short JM
    Mutat Res; 1994 Jun; 307(2):461-78. PubMed ID: 7514720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.
    Jakubczak JL; Merlino G; French JE; Muller WJ; Paul B; Adhya S; Garges S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9073-8. PubMed ID: 8799156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the workshops on statistical analysis of mutation data from transgenic mice.
    Gorelick NJ; Thompson ED
    Environ Mol Mutagen; 1994; 23(1):12-6. PubMed ID: 7907290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lambda Select cII Mutation Detection System.
    Besaratinia A; Tommasi S
    J Vis Exp; 2018 Apr; (134):. PubMed ID: 29757290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying in vivo somatic mutations using transgenic mouse model systems.
    Swiger RR
    Methods Mol Biol; 2005; 291():145-53. PubMed ID: 15502219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of transgenic mouse lacI/Z mutation assays in genetic toxicology.
    Ashby J; Tinwell H
    Mutagenesis; 1994 May; 9(3):179-81. PubMed ID: 7934956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.
    Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7958-62. PubMed ID: 1832771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Escherichia coli-derived mutation detected with the Big Blue cII mutant selectable assay.
    Ward TL; Prtenjaca A; Hill KA
    Environ Mol Mutagen; 2010 May; 51(4):344-8. PubMed ID: 20120017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dinitropyrenes induce gene mutations in multiple organs of the lambda/lacZ transgenic mouse (Muta Mouse).
    Kohara A; Suzuki T; Honma M; Oomori T; Ohwada T; Hayashi M
    Mutat Res; 2002 Mar; 515(1-2):73-83. PubMed ID: 11909756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of new transgenic Big Blue(R) mouse and rat primary fibroblast cell strains for use in molecular toxicology studies.
    Erexson GL; Watson DE; Tindall KR
    Environ Mol Mutagen; 1999; 34(2-3):90-6. PubMed ID: 10529731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic and germ cell mutagenesis in lambda lacZ transgenic mice treated with acrylamide or ethylnitrosourea.
    Krebs O; Favor J
    Mutat Res; 1997 Feb; 388(2-3):239-48. PubMed ID: 9057886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays.
    Morrison V; Ashby J
    Mutagenesis; 1994 Jul; 9(4):367-75. PubMed ID: 7968580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic characterization of the transgenic Big Blue Rat2 and Big Blue mouse embryonic fibroblast cell lines.
    Erexson GL; Cunningham ML; Tindall KR
    Mutagenesis; 1998 Nov; 13(6):649-53. PubMed ID: 9862199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
    Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experiences and future directions for transgenic mouse mutation assays.
    Suzuki T; Hayashi M; Sofuni T
    Mutat Res; 1994 Jun; 307(2):489-94. PubMed ID: 7514722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.